1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CEP78 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA PROSER1 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA RAB22A CTRPv2 pan-cancer AAC -0.17 3e-06
mRNA NBPF10 CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA SMAD9 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA DCHS1 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA SHC2 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA HTATIP2 CTRPv2 pan-cancer AAC -0.18 3e-06
mRNA RIC8B CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA ZDHHC17 CTRPv2 pan-cancer AAC 0.16 3e-06
Download CSV